Observational National Vaccine Study

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

May 18, 2022

Primary Completion Date

November 1, 2023

Study Completion Date

April 1, 2024

Conditions
COVID-19 Infection
Interventions
BIOLOGICAL

Taking biological samples (blood) and keeping records with phone calls

Within the scope of the study, no intervention will be made to the participants. According to the vaccination program implemented in Turkey, subjects who apply to the study centers for TURKOVAC vaccine will be invited to the study.

Trial Locations (8)

14280

T.R. Ministry of Health Abant Izzet Baysal University Training and Research Hospital, Bolu

26080

Eskişehir City Hospital Internal Medicine, Eskişehir

34865

T.R. Ministry of Health Kartal Dr. Lütfi Kirdar City Hospital Infectious Diseases, Istanbul

38080

Kayseri City Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Kayseri

38280

Erciyes University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Kayseri

41310

Health Sciences University Derince Training and Research Hospital, Kocaeli

06800

Ankara City Hospital Internal Medicine Clinic, Ankara

Unknown

Health Sciences University Kanuni Training and Research Hospital Infectious Diseases and Clinical Microbiology, Trabzon

All Listed Sponsors
lead

Health Institutes of Turkey

OTHER_GOV